The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

Recruiting now · Not applicable

Conditions studied: Leiomyoma (Uterine Fibroids), Adenomyoma of Uterus, Uterine Bleeding

In brief

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Key facts

Study ID

NCT07431788

Run by

Erkan Gol

People needed

60

Starts

2026-03-02

Expected to finish

2027-02-01

Last updated by the study team

2026-03-03

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women aged ≥18 years
• Planned total abdominal hysterectomy for benign indications
• Sexually active within the last 4 weeks
• Able to complete the Female Sexual Function Index (FSFI) questionnaire
• Provided written informed consent

You may not qualify if…

• Gynecologic malignancy
• Major additional pelvic reconstructive surgery
• Severe psychiatric or neurologic disorder
• Inability to complete follow-up assessments

Where it is running

• Bakirkoy Dr. Sadi Konuk Training and Research Hospital — Istanbul, Istanbul, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.